Onconetix (ONCO) Stock Statistics & Valuation Metrics

Onconetix has a market cap or net worth of $3.20M. The enterprise value is -$3.09M.

Onconetix has 3,949,107 shares outstanding. The number of shares has decreased by -2.65% in one year.

Onconetix’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -40.12%.

The current PE Ratio of Onconetix is ―. Onconetix’s PEG ratio is 0.17.

In the last 12 months, Onconetix had revenue of 815.37K and earned -14.03M in profits. Earnings per share was -4.73.

In the last 12 months, operating cash flow was -10.31M and capital expenditures 3.00, giving a free cash flow of -10.31M billion.

Onconetix pays an annual dividend of ―, resulting in a dividend yield of ―

Onconetix upcoming earnings date is May 10, 2024, After Close (Confirmed).

Onconetix as a current ratio of 0.66, with Debt / Equity ratio of 1.39%

In the past 12 months, Onconetix has paid 525.00 in taxes.

Onconetix EV to EBITDA ratio is -18.91, with an EV/FCF ratio of -25.92.

Onconetix has $5.94M in cash and marketable securities with $187.13K in debt, giving a net cash position of $5.76M billion.

Gross margin is 80.40%, with operating margin of -778.16%, and net profit margin of -1720.98%.

The average price target for Onconetix is ―, which is 11.43% higher than the current price. The consensus rating is ―